Versigent completes spin-off from Aptiv and begins trading on NYSE as VGNT
Aptiv PLC completed the spin-off of Versigent on April 1, 2026, distributing all Versigent ordinary shares to Aptiv shareholders, and Versigent began trading on the NYSE as VGNT that day. The company took on $1.35 billion in senior secured credit facilities and $1.6 billion in senior unsecured notes, with proceeds used to pay a dividend to Aptiv, and it appointed a new CEO and CFO effective with the spin-off.
Key points
- Aptiv shareholders of record on March 17, 2026 received one Versigent ordinary share for every three Aptiv shares held.
- Credit agreement includes a $500 million five-year term loan A, fully drawn March 27, 2026, and an $850 million five-year revolving credit facility.
- Cyprium Corporation and Cyprium Holdings Luxembourg issued $800 million of 6.125% notes due 2031 and $800 million of 6.375% notes due 2034 on March 18, 2026.
- Joseph T. Liotine was appointed Chief Executive Officer and Douglas R. Ostermann Chief Financial Officer, effective with the spin-off; Paul Meister became non-executive Chair.
The filing
Written by AI on Nov 8, 2026, 7:03 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 01, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.